JACK WEINSTEIN, Senior Advisor is one of Avalon’s healthcare/life sciences subject matter experts. For over 20 years, Jack has been an investment banker including as Head of Healthcare for three firms. At Catalyst Pharmaceuticals (Nasdaq: CPRX), a specialty pharmaceutical company, Jack was CFO, VP of Business Development and Treasurer. As part of CPRX’s senior management, he in?licensed two prescription drugs, and raised over $35 million in private and public equity financing, including a full?blown IPO. Jack brings additional insights based on skills gained as an operator and equity investor. As a General Partner of a private equity fund, he raised capital for the fund, evaluated investments, served as a Board of Director member and actively assisted portfolio companies develop and implement strategic acquisitions and growth plans. As an operating executive, he restructured a division of a healthcare services and consulting company to make it a viable independent entity. Jack earned his MBA from the Harvard Business School, and graduated from the University of Miami with a BM degree, magna cum laude. Jack also holds FINRA Series 79 and 63 Licenses.